Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk

This prospective cohort study of nearly 15,000 asymptomatic individuals examined the independent and combined associations of elevated lipoprotein(a) and family history of coronary heart disease with long-term cardiovascular risk.

Both elevated Lp(a) and family history were independently associated with increased ASCVD and CHD risk after adjustment for traditional risk factors. Their combination had an additive or multiplicative effect — individuals with both risk factors had substantially higher event rates than those with either alone. Adding Lp(a) and family history together improved risk reclassification metrics beyond standard risk models.

The clinical utility is in identifying primary prevention patients who warrant closer attention despite apparently average risk on standard calculators. A patient with a strong family history and elevated Lp(a) faces a compounded inherited risk load — one through the family history proxy of shared genetic and environmental exposures, the other through Lp(a) specifically. Together they point toward unusually high lifetime vascular burden.

We rate the evidence strong. A well-conducted prospective cohort demonstrating the independent and additive value of measuring Lp(a) alongside family history — supporting routine Lp(a) testing as a tool to sharpen primary prevention risk stratification.